Yang-Jing Xue

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 3

Top Topics

Percutaneous Coronary Intervention

Acute Myocardial Infarction

Reactive Oxygen Species

Top Venues

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Zhi-Hui Lin, Hua-Qiang Xiang, Yong-Wei Yu, Yang-Jing Xue, Chang Wu, Cong Lin, Kang-Ting Ji
Dihydroartemisinin alleviates doxorubicin-induced cardiotoxicity and ferroptosis by activating Nrf2 and regulating autophagy. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (10) (2024)
Zhi-Hui Lin, Hua-Qiang Xiang, Yong-Wei Yu, Yang-Jing Xue, Chang Wu, Cong Lin, Kang-Ting Ji
Dihydroartemisinin alleviates doxorubicin-induced cardiotoxicity and ferroptosis by activating Nrf2 and regulating autophagy. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (10) (2024)
Yang-Pei Peng, Ming-Yuan Huang, Yang-Jing Xue, Jia-Lin Pan, Cong Lin
Association of Hyperhomocysteinemia with Increased Coronary Microcirculatory Resistance and Poor Short-Term Prognosis of Patients with Acute Myocardial Infarction after Elective Percutaneous Coronary Intervention. BioMed research international 2020 (2020)